Agelaia-MP [N2F,K5F,L6R,I10D,I11del,D12V]

General Information


DRACP ID  DRACP04098

Peptide Name   Agelaia-MP [N2F,K5F,L6R,I10D,I11del,D12V]

Sequence  IFWLFRGKADVAL

Sequence Length  13

UniProt ID  P69436 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  7JGX 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C76H114N18O16

Absent amino acids  CEHMNPQSTY

Common amino acids  AFL

Mass  175009

Pl  9.69

Basic residues  2

Acidic residues  1

Hydrophobic residues  9

Net charge  1

Boman Index  246

Hydrophobicity  94.62

Aliphatic Index  127.69

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  5500

Absorbance 280nm  458.33

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33244888

Title  Antimicrobial and Anticancer Properties of Synthetic peptide Peptides Derived from the Wasp Parachartergus fraternus

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17045

DRACP is developed by Dr.Zheng's team.